Allogene Therapeutics
ALLO
#7442
Rank
$0.31 B
Marketcap
$1.44
Share price
4.35%
Change (1 day)
-63.64%
Change (1 year)

Allogene Therapeutics (ALLO) - Cash on Hand

Cash on Hand as of December 2024 : $0.29 Billion USD

According to Allogene Therapeutics 's latest financial reports the company has $0.29 Billion USD in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Allogene Therapeutics - Cash on Hand chart (from 2018 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31$0.29 B-34.82%
2023-12-31$0.44 B-13.27%
2022-12-31$0.51 B13.12%
2021-12-31$0.45 B-44.76%
2020-12-31$0.82 B56.05%
2019-12-31$0.53 B15.49%
2018-12-31$0.45 B
2017-12-31N/A

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
$0.25 B-12.49%๐Ÿ‡บ๐Ÿ‡ธ USA